Insys Therapeutics founder John Kapoor has become the first pharmaceutical boss to be convicted in a case linked to the US opioid crisis.
As we have been pointing out for many years now, towards the goal of expanding its markets, the pharmaceutical industry’s trillion-dollar-a-year business model is based on creating worldwide drug dependencies. Not only is the US opioid addiction crisis fully consistent with this analysis, the conviction of John Kapoor finally eliminates any remaining pretense that the pharmaceutical industry operates on ethical principles.
Found guilty of bribing doctors to prescribe highly addictive opioid painkillers to patients, Kapoor had also been deliberately misleading insurance companies as a means of boosting sales. By demonstrating that the primary goal of the pharmaceutical industry is to increase profits, his conviction once again reminds us that terminating the ‘business with disease’ is an essential step towards the creation of a preventive system of healthcare based on science-based natural health approaches.